| Juan Jesus Rendon Garcia, MD | |
|
1801 S 5th St Ste 207, Mcallen, TX 78503-2932 | |
| (956) 631-0393 | |
| (956) 682-4689 |
| Full Name | Juan Jesus Rendon Garcia |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 1801 S 5th St Ste 207, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417180142 | NPI | - | NPPES |
| 8DK720 | Other | TX | BCBS TX |
| 309697601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0102X | Surgery - Surgical Critical Care | P3423 (Texas) | Secondary |
| 2086S0127X | Surgery - Trauma Surgery | P3423 (Texas) | Secondary |
| 208600000X | Surgery | P3423 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Texas Health System | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcallen Hospitalist Group Pllc | 9830113836 | 99 |
News Archive
Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials.
Patients at increased risk for gastrointestinal cancer now have access to a new multidisciplinary program at Loyola University Health System.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its diosmectite, the Active Pharmaceutical Ingredient (API) in Simcere's branded generic drug Biqi, has passed EU-GMP inspection. This enables Simcere to market diosmectite in the European Union countries.
At a time when several U.S. health insurers have discontinued payment for use of the sedative propofol during most screening colonoscopies, physicians at the University of Pennsylvania School of Medicine have discovered that an alternative way to administer the drug could both save millions of health care dollars and provide a safer way to deliver optimal pain relief.
› Verified 9 days ago
| Entity Name | Mcallen Hospitalist Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356361976 PECOS PAC ID: 9830113836 Enrollment ID: O20060117001076 |
News Archive
Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials.
Patients at increased risk for gastrointestinal cancer now have access to a new multidisciplinary program at Loyola University Health System.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its diosmectite, the Active Pharmaceutical Ingredient (API) in Simcere's branded generic drug Biqi, has passed EU-GMP inspection. This enables Simcere to market diosmectite in the European Union countries.
At a time when several U.S. health insurers have discontinued payment for use of the sedative propofol during most screening colonoscopies, physicians at the University of Pennsylvania School of Medicine have discovered that an alternative way to administer the drug could both save millions of health care dollars and provide a safer way to deliver optimal pain relief.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Jesus Rendon Garcia, MD Po Box 3046, Malvern, PA 19355-0746 Ph: (956) 631-0393 | Juan Jesus Rendon Garcia, MD 1801 S 5th St Ste 207, Mcallen, TX 78503-2932 Ph: (956) 631-0393 |
News Archive
Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials.
Patients at increased risk for gastrointestinal cancer now have access to a new multidisciplinary program at Loyola University Health System.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that its diosmectite, the Active Pharmaceutical Ingredient (API) in Simcere's branded generic drug Biqi, has passed EU-GMP inspection. This enables Simcere to market diosmectite in the European Union countries.
At a time when several U.S. health insurers have discontinued payment for use of the sedative propofol during most screening colonoscopies, physicians at the University of Pennsylvania School of Medicine have discovered that an alternative way to administer the drug could both save millions of health care dollars and provide a safer way to deliver optimal pain relief.
› Verified 9 days ago
Dr. Alejandro Garza, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 300, Mcallen, TX 78504 Phone: 956-362-8170 Fax: 956-362-8168 | |
Dr. Jorge Luis De La Garza, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 224 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-0066 Fax: 956-971-0072 | |
Mr. Jose Luis Almeda, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 201, Mcallen, TX 78504 Phone: 569-362-5433 Fax: 569-362-2420 | |
Dr. Diego R Camacho, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 416 Lindberg Ave, Mcallen, TX 78501 Phone: 956-630-4161 Fax: 956-664-1398 | |
Fredricka M Borland, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 E Savannah Ave, Bldg A, Mcallen, TX 78503 Phone: 956-631-8155 Fax: 956-631-8187 | |
Angel J Tamez, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 E Ridge Rd Ste 106, Mcallen, TX 78503 Phone: 956-992-0404 Fax: 956-992-0414 | |
Dr. Roy Dewayne Edwards, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 300, Mcallen, TX 78504 Phone: 956-362-8170 Fax: 956-362-8168 |